Alt investors have opportunity to lead altimmune, inc. securities fraud lawsuit

Los angeles , may 23, 2024 /prnewswire/ -- glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against altimmune, inc. ("altimmune" or the "company") (nasdaq: alt). class period: december 1, 2023 – april 26, 2024 lead plaintiff deadline: july 5, 2024 if you wish to serve as lead plaintiff of the altimmune lawsuit, you can submit your contact information at www.glancylaw.com/cases/altimmune-inc/.
ALT Ratings Summary
ALT Quant Ranking